PIA
REGN icon

Perennial Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Perennial Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Buy
375
+14
+4% +$10.7K 0.02% 404
2025
Q4 		$278K Buy
+361
New +$245K 0.02% 395
2025
Q2 		– Sell
-329
Closed -$209K – 496
2025
Q1 		$209K Buy
+329
New +$226K 0.02% 401

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Perennial Investment Advisors's REGN Position: Q1 2026 in Review

Perennial Investment Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 3.9% in Q1 2026, buying an estimated $10.7K and bringing the position to 375 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #404.

Perennial Investment Advisors first reported a position in REGN in Q1 2025 and has held it in 3 quarters since. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Perennial Investment Advisors held 375 shares of Regeneron Pharmaceuticals worth $289K as of Q1 2026.
  • Perennial Investment Advisors bought 14 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $10.7K.
  • Regeneron Pharmaceuticals made up 0.02% of Perennial Investment Advisors's portfolio in Q1 2026, its #404 holding.
  • Perennial Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.